Fudan University Shanghai Cancer Center at SABCS 2026

Dec 8–11, 2026 San Antonio, TX ~11k attendees Website

Fudan University Shanghai Cancer Center brings 18 presentations to SABCS 2026 in San Antonio. The Shanghai cancer center presents on neoadjuvant immunotherapy in triple-negative disease, antibody-drug conjugates, ctDNA-guided treatment and AI-guided choice of HER2 therapy.

OrganizationSABCS 2026 Attendance
Hospitals
University-affiliated cancer center in Shanghai providing cancer care and conducting research.
Poster
Wed Dec 9
12:30–2pm
Poster
Wed Dec 9
12:30–2pm
Poster
Wed Dec 9
12:30–2pm
Proteomics specifically identifies a C5-PIEZO1⁺ endothelial cell axis mediating immunotherapy resistance in triple-negative breast cancer
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine
Poster
Wed Dec 9
5–6:30pm
Talk
Wed Dec 9
6:10–6:18pm
Part of Rapid Fire 4
Safety and preliminary efficacy of SYS6010 monotherapy in patients with HER2-negative, EGFR-expressing breast cancer
Stars at Night 1-2
Experimental Therapeutics and Early Phase Trials

Explore the full SABCS 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full SABCS 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Fudan University Shanghai Cancer Center

Tell us what you sell and we’ll find the people at Fudan University Shanghai Cancer Center most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction